Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. - Wikidata - awgldk - TriplyDB

Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice.

Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice.

http://www.wikidata.org/entity/Q50728256

about

Redox-directed cancer therapeutics: molecular mechanisms and opportunities Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS Targeting NADPH oxidases for the treatment of cancer and inflammation Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling Vasculogenesis in infantile hemangioma.The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk.Critical review of topical management of oral hairy leukoplakia.NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells Gentian violet: a 19th century drug re-emerges in the 21st century Updates of reactive oxygen species in melanoma etiology and progression.Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasis.Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors.Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells.Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome.Disseminated pyoderma gangrenosum: role for vascular endothelial growth factor and hypoxia inducible factor-2.Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors Redox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell lines NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.NHERF-2 maintains endothelial homeostasis.Why targeted therapy hasn't worked in advanced cancer.Expression of angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannoma Novel characterization of bEnd.3 cells that express lymphatic vessel endothelial hyaluronan receptor-1.Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.Kaposi sarcoma as a model of oncogenesis and cancer treatment.Pathogenesis of infantile haemangioma.Application of angiogenesis to clinical dermatology.Dusp-5 and Snrk-1 coordinately function during vascular development and disease.Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.The role of angiogenesis in the pathogenesis of psoriasis.Gentian violet induces wtp53 transactivation in cancer cells Recent progress in studies of infantile hemangioma.Novel antiangiogenic agents in dermatology.Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets.

P2860

Q24645584-2ED1394D-4CBB-4E97-9519-9ABC81E192AA Q26751153-F95C1866-9F41-4AEB-88F6-F6F1DC5BB670 Q26821775-6FBDFACA-66E6-4DC3-BA1C-7A00931F72B5 Q26851163-6601DD49-287C-4D75-A2B3-5747D18F7CD0 Q26861119-5BE5A177-BAF2-4FA0-9F05-338CE60B5985 Q28728015-DAEC8F73-7A35-4593-BC7A-784494B4EDFA Q28743072-5D74DD5C-13B2-427B-9199-B99464CAF7D1 Q33427340-C5DE2BDA-5E1E-49AF-967D-94DBEC1E8D5B Q33607327-15EDED26-4C58-4B6C-B04B-8D200E43F453 Q33632757-04E2A922-FF4F-4133-BC9C-6FCED6755371 Q33845086-0923035A-61C9-419B-A8AF-58F89143AA3F Q33898234-A67933CA-6A26-48A5-861A-096035FECF48 Q34044788-924F9853-98D7-4BA8-9BD3-DAF0B6B1D146 Q34115516-B4B6E426-8D16-4A3E-8DF6-6F1A305D1245 Q34377198-8191039A-67C8-4EAF-8378-AF0722A3EF62 Q34403921-D3527692-5477-4C35-A1E4-C1959E253934 Q34558182-2B7DC3E9-4815-4433-9D71-32EB7D962466 Q34659698-5DBDDEC7-83EA-4618-BD53-331E2135328A Q34778819-23B05592-8CF8-465B-8C76-664AAD79AA44 Q34883323-95E6E51F-D4FB-4D15-A2EF-3936DFEE8C19 Q35546459-C49EF1D4-37EC-4244-9D21-2F3F79498DBC Q35824748-BE798670-43F8-49E5-AF8A-28A6E0214B94 Q35880182-CE9C54CF-D23C-4D9F-9130-C6BC64416CB3 Q35985407-287463D4-92B2-438E-B7C0-BAF133C0099C Q36010234-7CE3EE2B-DD3E-42E5-9F27-E7D5B9747F67 Q36014536-6804AC10-863E-4EF5-B286-5099D60BF560 Q36179058-2ECF0FCF-A635-4FB4-B017-59DE9259759B Q36258963-3B602139-CA0D-48FC-B2E6-95753D2AF849 Q36467382-4875784A-B8AF-4679-AE26-F49475F45BF0 Q36646486-00C7A56F-0D56-47B3-9784-3E4173C1CC18 Q36731435-42562D77-8231-44FA-A5FC-B72273290405 Q37001304-AB04A328-0768-4D51-9173-72966F054EF8 Q37079239-C381001F-63B7-44CE-BA5C-39DD99DB5B21 Q37082017-361ECC68-5EE2-408A-8E8D-17A1F4F307B8 Q37286610-EF4F67A7-DB9F-4816-9806-B94679168D61 Q37622941-FA552F0A-5E9D-4CD5-AFBC-B76079549145 Q37688664-0B63238C-E0F1-48E1-8E53-6716E05DF91E Q37805629-64638DBC-7EEE-4813-9E53-6DB54069525B Q37822512-D59DC772-7AF8-48B5-BE0C-D69DE158B9FF Q38205041-20821C64-ED38-4A3E-8C11-CD299F286ABA

P2860

Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice.

http://www.wikidata.org/entity/Q50728256

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@en

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@nl

type

label

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@en

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@nl

prefLabel

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@en

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@nl

P1433

Q50728256-A80278F5-C41A-41E5-8077-D1C4BD6B0A10

P1476

Q50728256-DA0843FF-601C-4786-ABB7-3D7F8505CEA1

P2093

Q50728256-40729A27-749C-4400-A417-2796ECA796D3

Q50728256-45E32D96-7C42-428E-854E-1466389FF472

Q50728256-480312D8-CDD0-483D-A8B9-5D41641E7DC1

Q50728256-5B687A46-3DFF-46CE-9A19-D4D08CF140B1

Q50728256-6D8D356A-0B68-4259-A23C-5198C8159BDB

Q50728256-6F8D70F9-EA06-4D02-95BD-879D35D984D7

Q50728256-7562791D-924D-4F88-84FE-64B74F49FC3C

Q50728256-809F29A1-9939-4826-B8FA-2F5692F2D330

Q50728256-A8D326DE-D49B-4F57-BF34-E3BC2517EEE5

Q50728256-B3AE7F30-D627-41FE-A22E-ECA410B3A159

P2888

Q50728256-5AC80149-7A81-4AB0-9307-68EA8139E9C5

P304

Q50728256-DBCE4D03-EFE8-4A67-ABAD-355F2BD0A4FC

P31

Q50728256-CEB24C22-7BB3-4459-8C12-AD5C8AE70CBD

P356

Q50728256-2C11C8B4-755E-471D-B6A6-C97F02729C10

P407

Q50728256-9B54423B-F349-401B-A4CC-3F88DE9E67B2

P433

Q50728256-F9AABC45-A35C-4223-8D7E-06901C2BA9A6

P478

Q50728256-B8B63112-9996-4789-9E69-A8ABBF2D4DC9

P577

Q50728256-62F0CAB9-B498-41AF-B9A5-D1C3B467DD07

P5875

Q50728256-601C687A-8616-439F-B351-7BB90C439D18

P6179

Q50728256-B17F69C1-25CD-49C0-A014-E350C9F2AA00

P698

Q50728256-1A69A424-C0D4-454E-A8D9-DE0951E32F03

P921

Q50728256-D83B1020-87BD-4CE8-B064-BD5B3A4450EA

P356

P1433

Journal of Investigative Dermatology

P1476

Pharmacologic blockade of angi ...... nst model hemangiomas in mice.

@en

P2093

Albert Losken

http://www.w3.org/2001/XMLSchema#string

Allie Sohn

http://www.w3.org/2001/XMLSchema#string

Baskaran Govindarajan

http://www.w3.org/2001/XMLSchema#string

Betsy N Perry

http://www.w3.org/2001/XMLSchema#string

Carol O Carrillo

http://www.w3.org/2001/XMLSchema#string

Celina Sturk

http://www.w3.org/2001/XMLSchema#string

Dan Dumont

http://www.w3.org/2001/XMLSchema#string

Ella Ioffe

http://www.w3.org/2001/XMLSchema#string

Francesca Cerimele

http://www.w3.org/2001/XMLSchema#string

George D Yancopoulos

http://www.w3.org/2001/XMLSchema#string

P2888

P304

2316-2322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.JID.5700413

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7040514

http://www.w3.org/2001/XMLSchema#string

P6179

1043734392

http://www.w3.org/2001/XMLSchema#string

P698

16741507

http://www.w3.org/2001/XMLSchema#string

P921